| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 106,819 | 110,695 | 117,440 | 136,747 | | Cost of Revenue | (32,155) | 69,680 | 73,087 | 45,232 | | | Gross Profit | 138,974 | 41,015 | 44,353 | 91,515 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 109,615 | 14,891 | 15,736 | 56,289 | | Non Recurring | 2,327 | 15,762 | 944 | 35,455 | | Others | 5,113 | 6,263 | 5,973 | 5,865 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 21,919 | 4,099 | 21,700 | (6,094) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 827 | 4,144 | 90 | (3,188) | | Earnings Before Interest And Taxes | 22,746 | 8,243 | 21,790 | (9,282) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 22,746 | 8,243 | 21,790 | (9,282) | | Income Tax Expense | 8,569 | 3,297 | 8,718 | (757) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 14,177 | 4,946 | 13,072 | (8,525) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 14,177 | 4,946 | 13,072 | (8,525) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $14,177 | $4,946 | $13,072 | ($8,525) |
|
0.51% Nasdaq 
Income Statement
